TrialCNS drugs2014

Assessment of the abuse liability of a dual orexin receptor antagonist: a crossover study of almorexant and zolpidem in recreational drug users.

Hans G Cruz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.